Press Releases

Trillium Strengthens its Board of Directors - November 5, 2008
Click HERE for the full story.

Trillium raises $12 million - September 18, 2008
Click HERE for the full story.

TTI Receives Orphan Drug Status - December 19, 2006
Click HERE for the full story.

Trillium adds late stage preclinical program - April 10, 2006
Click HERE for the full story.

Canada's Top 10 Investment Prospects Named - November 7, 2005
Click HERE for the full story.

Trillium acquires Arthron Ltd. - October 6, 2005
Click HERE for the full story.

Trillium recognized with national award - May 26, 2005
Click HERE for the full story.

Trillium and Genentech enter into global license agreement - December 14, 2004
Click HERE for the full story.

Professor Marc Feldmann Joins Trillium Therapeutics' Scientific Advisory Board - June 8, 2004
Click HERE for the full story.

Trillium Adds Major Cytokine Receptor Antagonist Program - June 2, 2004
Click HERE for the full story.

Trillium Therapeutics Welcomes Dr. Michael Moore to Board of Directors - February 23, 2004
Click HERE for the full story.

Trillium Therapeutics Raises an Additional $6.0 Million to Close Series A Round at $13.5 Million - February 5, 2004
Click HERE for the full story.

Trillium Therapeutics and Medarex announce Collaboration to develop Fully Human Antibody Therapeutics - October 2, 2003
Click HERE for the full story.

Trillium Therapeutics Inc. announces Internationally Renowned Scientists to join New Scientific Advisory Board - September 12, 2003
Click HERE for the full story.

Julia Levy and Elizabeth Corsi join Trillium Therapeutics' Board of Directors - July 15, 2003.
Click HERE for the full story.

Transplantation Technologies announces name change to Trillium Therapeutics Inc. and arrival of Dr. Robert Uger as Director, Research & Development –  May 13, 2003.
Click HERE for the full story.